A multicenter Spanish study of atropine 0.01% in childhood myopia progression

To evaluate the efficacy and safety of atropine 0.01% eye drops for myopia control in a multicentric pediatric Spanish cohort. An interventional, prospective, multicenter study was designed. Children aged between 6 and 14 years, with myopia between − 2.00 D to − 6.00 D, astigmatism 

Saved in:
Bibliographic Details
Published in:Scientific reports 2021-11, Vol.11 (1), p.21748-9, Article 21748
Main Authors: Pérez-Flores, Inés, Macías-Murelaga, Beatríz, Barrio-Barrio, Jesús
Format: Article
Language:English
Subjects:
692/699/3161
692/699/3161/3178
Acuity
Adolescent
Anterior chamber
Atropine
Atropine - administration & dosage
Child
Childhood
Children
Disease Progression
Eye
Female
Humanities and Social Sciences
Humans
Male
multidisciplinary
Mydriatics - administration & dosage
Myopia
Myopia - drug therapy
Patients
Pediatrics
Prospective Studies
Risk factors
Science
Science (multidisciplinary)
Side effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the efficacy and safety of atropine 0.01% eye drops for myopia control in a multicentric pediatric Spanish cohort. An interventional, prospective, multicenter study was designed. Children aged between 6 and 14 years, with myopia between − 2.00 D to − 6.00 D, astigmatism 
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-021-00923-1